Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

URGNUroGen Pharma Ltd.

$917M

Q3 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$6M

Net Income

-$8M

EPS (Diluted)

$-0.67

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$513,000

Balance Sheet

Total Assets

$9M

Total Liabilities

$4M

Stockholders' Equity

$5M

Cash & Equivalents

$8M

← FY 2016 All Quarters Q4 2016 →

URGN Q3 2016 Earnings — UroGen Pharma Ltd. Revenue & Financial Results | Market Cap Arena